SlideShare a Scribd company logo
PRESENTED BY:
SACHITA
The words, “osseous” in latin means bony, and
“osteon” in Greek means “bone”, and ‘‘myleos’’
means marrow; and “itis” in Greek means
inflammation.
In 1834, Nelaton first coined the word
“Osteomyelitis”.
By definition osteomyelitis (OML) is an
inflammation of medullary portion of bone or bone
marrow or cancellous bone.
 Osteomyelitis is an extensive inflammation of a
bone. It involves the cancellous portion, bone
marrow ,cortex and periosteum. ( Laskin1989)
The inflammation may be acute, subacute or
chronic.
It may be localized ; or may involve a larger portion
of bone.
It may be suppurative or nonsuppurative.
The factors that predispose to osteomyelitis are:
1. Conditions affecting host resistance or defenses
2. Compromised vascular integrity and perfusion in
the host bone, at the local, regional or systemic level
3. Virulence of microorganisms
1. Conditions that alter host defenses would
include chronic debilitating diseases, such as
diabetes mellitus, agranulocytosis, leukemia ,
severe anemia, malnutrition, drug abuse, chronic
alcoholism, sickle cell disease, and febrile
illnesses such as typhoid, tuberculosis.
2. Conditions that alter vascularity of bone include
therapeutic irradiation, osteoporosis, Paget’s
disease, fibrous dysplasia, peripheral vascular
disease, bone malignancy, metallic bone necrosis
(caused by mercury, bismuth, and arsenic).
3. Virulence of organisms: Certain organisms precipitate
thrombi formation by virtue of their destructive
lysosomal enzymes (Hudson 1993). Lysosomal and
enzymatic degradation of host tissue, along with
microvascular thrombosis brought about by pathogen
borne bioactive peptides and chemoattracted leukocytic
purulence, forms a protective barrier for the infectious
foci, allowing organisms to proliferate in an enriched
host medium, while protected from the host immunity.
Osteomyelitis of the jaws is caused by:
Odontogenic infections: Primarily odontogenic infections
originating from pulpal or periodontal tissues,
pericoronitis, infected socket, infected cyst, tumor, etc.
Trauma: Is the second leading cause : (a) Especially,
compound fracture and (b) Surgery – iatrogenic cause.
Infections of orofacial regions derived from : Periostitis
following gingival ulceration, lymph nodes infected from
furuncles, lacerations, peritonsillar abscess.
Infections derived by hematogenous route: Furuncle on
face, wound on the skin, upper respiratory tract infection,
middle ear infection, mastoiditis, systemic tuberculosis.
The medications linked to osteomyelitis are steroids,
chemotherapeutic agents and bisphosphonates. Local
conditions that adversely affect the blood supply can also
predispose the host to a bony infection.
Osteomyelitis is initiated from a contiguous focus of
infection or by hematogenous spread
Primary hematogenous osteomyelitis is rare in the
maxillofacial region , generally occurring in the very young
patients
The adult process is initiated by an inoculation of bacteria
into the jaw bones
The initial causative insult results in a bacteria induced
inflammation or cascade
In normal healthy patient, this process will be self-limiting
Osteomyelitis is an infectious process of the medullary
myeloid cavity of bone
In the craniofacial skeleton , only the mandible and the
calvarium have myeloid compartments
The important factor in the establishment of osteomyelitis
is the compromise in the blood supply .
Primary supply: The mandible is supplied by inferior alveolar
artery, except coronoid process, which is supplied by
temporalis muscle vessels.
Secondary supply: It is periosteal supply, which generally
runs parallel to cortical surface of bone, giving off nutrient
vessels, those penetrate cortical bone and anastomose with
the branches of inferior alveolar artery.
Venous drainage of mandible: There are two routes: (1) Via
inferior alveolar vein ; it runs upwards, and joins pharyngeal
plexus, and (2) It runs downwards, and joins external jugular
veins.
Waldron(1943) , gave an exhaustive morphologic description
of vascular morphology of mandible and associated structures
to account for spread of OML. He described mandibular
vascular support as being provided through multiple
arterial loops from a single major vessel, which renders
large portion of bone susceptible to necrosis with the
occurence of major vessel infectious thrombosis.
 Waldervogel (1970): described its relationship to vascular
support of long bones of developing and adult human
skeleton . He made several conclusions :
There tends to be segregation of vascular channels, which
act like “end organs”, due to lack of terminal collateral
anastomosis, ultimately, leading to vascular plugging by
bacteria, microthrombi or both.
When afferent vessels anastomose with medullary
channels
, there is a possibility of a decrease in venous flow with
associated areas of greater turbulence.
 There may be a reduction in host immune defense
mechanism associated with these vascular channels in
calcified tissue.
A true osteomyelitis infectious process does not occur in
the maxilla despite the presence of tooth follicle or
anatomic respiratory sinus cavities, including the nose.
It is rare , due to: (1) Extensive blood supply and
significant collateral blood flow in midface,
(2) Porous nature of membranous bone,
(3) Thin cortical plates, and
(4) Abundant medullary spaces. These preclude
confinement of infections within bone ; and permit
dissipation of edema and pus into soft tissues and
paranasal air sinuses.
The process of leading to OML is initiated by acute
inflammation, hyperemia, increased capillary permeability
and infiltration of granulocytes. Tissue necrosis occurs, as
proteolytic enzymes are liberated and as destruction of
bacteria and vascular thrombosis continues, there is a pus
formation.
The pus is a combination of necrotic tissue and dead
bacteria and white blood cells accumulate. When pus
accumulates, the intermedullary pressure increases
resulting in vascular collapse, venous stasis, and ischemia.
Subsequently, pus travels through Haversian and
nutrient canals and accumulates beneath the periosteum,
elevating it from the cortex ; and thereby further
reducing vascular supply. Compression of neurovascular
bundle accelerates thrombosis, ischemia, and infarction,
later resulting in paresthesia and sequestrum formation.
A sequestrum is defined as a portion of bone that
becomes separated from sound bone during the process of
necrosis.
Radiographically, the bone surrounding sequestrum
appears less densely mineralized than sequestrum itself,
since vascularity of vital bone creates relative
demineralization.
In the past, etiology of OML was associated with skin
surface bacteria, Staphylococcus aureus, and to a lesser
extent Staphylococcus epidermidis, or hemolytic
streptococci. However, the picture of S.aureus as primary
offending pathogen does not hold true with regard to OML
of tooth bearing bone.
Most of the cases are caused by aerobic Streptococci (alpha
hemolytic streptococci, Streptococcus viridans), anaerobic
streptococci; and other anaerobes, such as
Peptostreptococci, fusobacteria, and Bacteroides.
Other organisms, such as M. tuberculosis , T. Pallidum,
and Actinomyces species produce their respective specific
forms of OML.
Hence, established acute OML is usually a polymicrobial
disease and includes : Streptococci, Bacteroides,
Peptostreptococci and Fusobacteria.
A variety of classifications of various forms of the disease
are:
 Historically accepted classification : It is based on clinical
course. (A) Acute, (B) Chronic. The arbitrary time limit, to
identify acute from chronic form is of 1 month (Koorbusch
et al. 1992, Marx; 1992, and Mercuri ; 1992) .
Classification based on presence or absence of
suppuration:
Cierny et al. (1985) and Vibhagool (1993) developed a
classification and staging system; based on:
1. Anatomic location of infectious process,
2. Physiological status of the host,
3. Systemic or local factors affecting immune system,
metabolism, and local vascularity.
It may have the appearance of a typical
odontogenic infection. It can be localized and
widespread, with extensive sequestration and
possible pathological fracture.
It is caused by pyogenic organisms. OML in the tooth
bearing area, is polymicrobial in nature. The most
commonly found organisms in odontogenic OML is
Staphylococcus aureus, and Streptococcus pyogenes.
1. Odontogenic infections
2. Local traumatic injuries
3. Peritonsillar abscess
4. Furunculosis
5. Hematogenous infections
6. Infected compounded odontoma
7. Compound fractures of jaws are complicated by OML.
These are the common local cause of OML. These
infections may result from: periapical disease secondary to
pulp pathology, periodontal disease, pericoronitis of long
duration, infected odontogenic cyst, and infection of an
extraction wound or fracture site.
Injuries of gingiva are usually insignificant;
however may become serious in patients with low
resistance (Ivy and Cook, 1942).
Instruments used for extraction of teeth.
PERITONSILLAR ABSCESS: It has been
recorded as a cause of OML of ascending ramus.
FURUNCULOSIS: Of skin is a rare cause of
OML.
HEMATOGENOUS INFECTION : It may
cause multiple sites of OML. The organisms enter
the bloodstream through a minor wound in the
skin, or infection of upper respiratory tract, or
infection of middle ear.
1. Undernourished children
2. Lowered general resistance of body
3. Generalized body diseases, such as : diabetes,
leukemia and agranulocytosis
4. Acute illnesses such as influenza, measles,
scarlet fever, pertussis and pneumonia, etc.
OCCURENCE: In adults, it is more common in
mandible and involves alveolar process, angle of
mandible, posterior part of ramus and coronoid process.
OML of condyle is reportedly rare (Linsey, 1953).
 Early cases are characterized by :
Generalized constitutional symptoms: high
intermittent fever, malaise, nausea, vomiting,
anorexia.
Continuous intense pain in the affected area.
Intermittent paresthesia or anesthesia of the lower lip,
which helps the clinician to differentiate this condition
from alveolar abscess.
Facial cellulitis, or indurated swelling of moderate size,
which is more confined to the periosteal envelope and its
contents (I) Thrombosis of inferior alveolar vasa
nervorum, (II) Rise in pressure from edema in inferior
alveolar canal (III) Teeth are tender to percussion and
loose, and presence of trismus.
In children : fluminating, severe and serious, involvement
of maxilla or mandible, complicated by the presence of
unerupted developing teeth buds, which become necrotic
and act as foreign bodies and prolong the disease
process.
Long- term involvement of temporomandibular joint
(TMJ) can cause ankylosis of TMJ and subsequently
affect the growth and development of facial
structures.
Laboratory studies : Show mild leukocytosis [poly-
morphonuclear leukocytes (PMNL)] and
albuminuria.
Established cases are characterized by :
Deep pain, malaise, fever, dehydration, anorexia
Teeth in involved area begin to loosen and become
sensitive to percussion.
Purulent discharge through sinuses :
(a) Intraorally, around gingival sulcus or through buccal
vestibule, and
(b) Extraorally on the face, through cutaneous fistulae
Fetid odor is often present .
Dehydration, acidosis and toxemia.
Regional lymphadenopathy is usually present.
Laboratory studies show: moderate leukocytosis, slightly
elevated erythrocyte sedimentation rate (ESR) and C
reactive protien, anemia and albuminuria.
MANAGEMENT –
Removal of the cause and debridement with antibiotic
cover.
It can be primary: resulting from organisms which are less
virulent, and secondary occuring after acute OML, when
the treatment did not succeed in eliminating the infection
The clinical features are usually limited to :
Pain and tenderness : the pain is minimal
Nonhealing bony and overlying soft tissue wounds with
induration of soft tissues,
Intraoral or extraoral draining fistulae.
Thickened or “wooden” character of bone.
Enlargement of mandible because of deposition of
subperiosteal new bone .
Sterile abscess (Brodie’s abscess) , common to long bones
is rare in jaws.
Teeth in the area tend to become loose and sensitive to
palpation and percussion.
It is made on basis of : history, clinical examination and
radiological findings — 1) Presence of sequestra, (2)
Areas of suppuration involving the tooth –bearing area of
jaw bone, not responding to debridement and
conservative therapy, (3) Regional or systemic
compromise of immune response, microvascular
decompensation or both.
Several sequalae/complications can occur as a result of
OML of jaws.
Neoplastic transformation: With chronic OML,
neoplastic conversion of inflammatory metaplasia to
squamous cell carcinoma is noted. The incidence
reported is 0.2-1.5%.
Discontinuity defects: The defects can be (a)
spontaneous (b) surgically induced, necessitating jaw
reconstruction ; once infection is resolved.
Progressive diffuse sclerosis : It involves the medullary
and cortical portions of maxillofacial skeleton, especially
mandible, over a period of time.
The overall treatment modalities include:
1. Conservative treatment
2. Surgical treatment
 The goal of the treatment is to:
1. Attentuate and eradicate proliferating pathological
organisms
2. Promote healing
3. Re-establish vascular permeability.
Successful treatment is based on the following
fundamental principles :
1. Early diagnosis with radiographic evaluation and tissue
histopathology diagnosis
2. Bacterial culture and sensitivity testing
3. Adequate, appropriate and prompt antibiotic therapy
4. Adequate pain control
5. Proper surgical intervention
6. Reconstruction, where indicated.
Complete bed rest
Supportive therapy: It includes – nutritional support, in
the form of high protein and high caloric diet, and
adequate multivitamins
Dehydration: Hydration orally or through
administration of IV fluids
Blood transfusion : In case, RBCs and hemoglobin is
low
Control of pain: It is controlled with analgesics.
Sedation may be employed for keeping patient
comfortable and allow to sleep.
Antimicrobial agents : Begin with empiric dual drug
therapy— Penicillin and metronidazole or single drug
Clindamycin. Definitive antimicrobial therapy can be
started after final culture and sensitivity test results are
obtained.
Antibiotics of value in treatment of OML include:
penicillins, penicillinase-resistant penicillins, clindamycin,
cephalosporins and erythromycins. Some of the newer
antibiotics which provide effective coverage include:
metronidazole, clindamycin, ticarcillin, clavulanic acid,
cephalosporins, vancomycin in combination with other
antibiotics, and fluoroquinolones.
Recommended antibiotic regimens for OML of jaws are as
follows:
Regimen I (1st choice) : As empirical therapy, penicillin
(penicillin V) is given.
Aqueous penicillin: 2 million units IV every 4 hourly.
Oxacillin: 1g IV every 4 hourly.
When the patient has been asymptomatic for 48-72 hours,
then switch to—penicillin V orally 500mg every 4 hourly,
with dicloxacillin 250 mg orally every 4 hourly for 2-4 weeks.
 Regimen II: It is based on culture and sensitivity results.
Penicillinase penicillinase-resistant penicillins, such as
oxacillin, cloxacillin, dicloxacillin, or flucloxacillin may be
given.
In case of allergy to penicillin, the following antibiotics are
prescribed, in order of preference: (i) Clindamycin 300-600
mg orally 6 hourly, (ii) Cephalosporin 250-500mg orally
every 6 hourly: (a) Cefazolin 500 mg 8 hourly, or (b)
Cephalexin 500 mg 6 hourly, (iii) Erythromycin 2g every 6
hourly IV, then 500 mg every 6 hourly orally.
Second choice: Clindamycin: It is effective against
penicillinase producing staphylococci, streptococci and
anaerobic bacteria including Bacteroides. It is used because
of its ability to diffuse widely in bone. It is nkt
recommended as first choice; as it is bacteriostatic, and
causes diarrhea due to pseudomembranous colitis.
Third choice : Cefazolin or Cephalexin : It is effective
against most cocci including penicillinase –producing
staphylococci, Gram-negative aerobic bacilli viz. E. coli ,
Klebsiella, and Proteus.
Cephalosporins are not recommended as first choice
because these are moderately effective against anaerobes
and because of broad spectrum coverage, which increases
antibiotic complications.
Fourth choice: Erythromycin : These drugs cannot be used
as first choice, as these are : (i) Bacteriostatic, and (ii)
rapidly develop resistant strains.
Over the last several decades, HBO therapy has
emerged as :
(i) a potent alternative to surgical reperfusion, and
(ii) as an adjunctive enhancement to host –immune
response.
Its use has increased in the treatment of refractory OML
and osteoradionecrosis (ORN) .
The hyperbaric oxygen therapy is indicated in cases of
osteomyelitis , which do not respond to routine
treatment due to presence of certain associated
conditions like irradiated jaw , osteosclerosis ,
osteoporosis , and geriatric patients.
It facilitates the healing of the bone and also helps in
combating the infection .
The HBO therapy involves the intermittent ,twice daily,
inhalation of 100% humidified oxygen under 2 atmospheric
pressure for 90 minutes .
HBO reduces the hypoxia within the affected tissues and
stimulates angiogenesis in the hypovascular tissues.
It enhances phagocytic activity of leukocytes to stimulate
fibroblast growth , increase in collagen formation and
promote growth of new capillaries.
Hyperbaric oxygen chamber : The patient is placed in a
chamber. Oxygen is given by mask or by hood .It is given for
5 days per week for 30, 60, or more dives at 2.4 ATA for 90
minutes , while breathing 100% oxygen twice daily.
 Marx protocol (1983 ):
• 30 initial dives, if improved then 60 dives completed
• Otherwise , sequestrectomy +30 dives
• If wound dehiscence , resection + 60 dives and 20 dives after
10 weeks
• Patient with pathological fracture , orocutaneous fistula are
given 30 dives more prior going to resection.
The surgical treatment modalities include:
1. Incision and drainage
2. Extraction of loose or offending teeth
3. Debridement
4. Decortication
5. Continuous or intermittent indwelling close catheter
irrigation
6. Sequestrectomy
7. Saucerization
8. Resection of jaw
9. Trephination
10. Immediate or delayed reconstruction with bone
graft.
Surgical intervention is done under antibiotic cover,
started atleast, 1-2 days prior to the procedure.
It should be done as soon as possible. It relieves the
pressure and pain caused by the accumulation of pus.
Incision of abscesses should be carried out intraorally or
extraorally depending upon the location. Evacuation of
pus by drainage, lessens absorption of toxic products and
prevents further spread of infection in the bone, thus,
helping in its localization. The consistency, color and odor
of the pus may provide important clues to the diagnosis
and initial treatment. Patients with compromised
systemic conditions or toxemia, surgical interference may
be postponed for 2-3 days.
The various methods employed for causing drainage from
the bone include: (i) Opening up the pulp chamber, (ii) By
making fenestration through cortical plate over the apical
area with a drill, (iii) In an edentulous area, especially,
posterior maxilla or maxillary tuberosity region, by making
an incision over the alveolar crest, and by making a
window, pus is evacuated and (iv) OML at the angle of
mandible or ascending ramus, drainage can be achieved by
a small incision made over the point of the greatest
tenderness, or just below the mandible.
 Extraction of loose or offending teeth: Sometimes,
drainage is achieved by extraction of offending teeth.
Debridement : followed by incision and drainage, thorough
debridement of affected area should be carried out. The area
may be irrigated with hydrogen peroxide and saline. Any
foreign body, necrotic tissue or small sequestrum should be
removed.
Decortication: Removal of dense chronically infected and
poorly vascularized, lateral and inferior cortical plates of
bone 1-2 cm beyond the area of involvement. Thus, an access
is provided to medullary cavity. Obwegeser (1960) advocated
this procedure, as it shortens healing time.
Decortication and mobilization of muscle flaps to achieve or
improve regional and systemic vascular supply to the involved
area have been used to bring the overlying vascular soft
tissue envelope to a closer proximity to infected spongiosa.
This will increase the blood supply and healing of the affected
area.
The steps in decortication are:
Creation of buccal flap by crestal incision extending along the
necks of the teeth.
Reflection of mucoperiosteal flap to the inferior border.
Removal of teeth in the involved area.
Removal of cortical plates —lateral and inferior border, with
chisel in one piece. Bone must be cut back to uninvolved
areas.
Bony bed should be thoroughly debrided and flaps should be
closed primarily and dead space is eliminated by applying
pressure bandage placed to keep vascularized soft tissue in
contact with bony bed.
Irrigation tubes should be placed through separate stab
incision and closed suction should be employed.
Continuous or intermittent indwelling closed catheter
irrigation : After intraoral sequestrectomy and
saucerization or decortication, two small pediatric
nasogastric feeding tubes, catheters or polyethylene drain
tubes, 3-4 mm in diameter and 6-10 inches long in length,
are placed against the bony bed through separate skin
incisions at some distance and secured with sutures. One
tube is connected to the low – pressure suction to allow
drainage of pus and serum and another is kept patent to
provide a route through which locally antibiotics may be
instilled in very high concentrations. Daily, first saline
irrigation followed by antibiotic instillation should be
repeated, until negative cultures are obtained. Systemic
antibiotics are also continued for atleast 2-3 months
following cessation of clinical evidence of disease.
Sequestrectomy: An integral part of definitive therapy. It helps
in establishment of local microvascular proliferation. It should
be undertaken through an intraoral incision; or extraoral (
submandibular) approach, depending upon the site of
sequestrum.
Saucerization: Excision of margins of necrotic bone overlying a
focus of OML. It is useful in chronic form, since it permits
removal of formed and forming sequestra with better
visualization. It is performed when removal of sequestrum
leaves a large cavity, and to eliminate the dead space to avoid
reinfection of extensive clot. It is performed with a large round
bur, so that when wound is closed, the soft tissues eliminate a
dead space. The buccal cortex is reduced to the level of
unattached mucosa, producing a saucer like defect.
Sequestrectomy and saucerization are to be carried out after
the acute phase has subsided; and the defense mechanism of
host and antimicrobial therapy have overcome the virulence
of organisms. In certain circumstances, after performing the
necessary surgical procedures, where the soft tissues cannot
be closed without leaving dead space, or because of rigid
fibrosis ; the wound may be packed with 2” ribbon gauze
soaked with Whitehead varnish.
Trephination Or fenestration is the creation of bony holes or
windows in the overlying cortical bone adjacent to the
infectious process for tissue ammoniation and
decompression of the medullary compartment. Drilling of
holes into the cortex and reaching medulla provides multiple
surgical transcortical ports, that allow vascular
communication between the periosteum and the medullary
cavity.
 Resection : It is rarely required. When full thickness of
segment of jaw is involved and a conservative approach
has failed to cure, resection of the part should be
considered. However, while exposing the affected area, the
only soft tissue related to the necrotic bone should be
elevated, to avoid devitalization of the adjoining cortex.
Immediate and/or delayed reconstruction : It has been
used successfully in cases of: (i) pathological fracture, (ii)
persistence of infection after decortication, and (iii) when
both cortical plates are markedly diseased . Iliac crest is
a desirable graft. A block of corticocancellous iliac crest
can be used or cancellous marrow is used. Stabilization
may be achieved with vitallium or titanium mesh that
also serves as a tray to contain the graft. Immediate
reconstruction offers the obvious advantage of shortening
the period of illness and speeding recovery and
rehabilitation. In cases, where immediate bone grafting
is contraindicated, a reconstruction plate is fixed as a
spacer.
Secondary bone grafting: This should be considered when
the wound has healed completely and is free of infection.
Postoperative care: It includes the following :(i) Continued
use of antibiotics, analgesics, and hot saline mouth rinses,
(ii) Adequate hydration, complete rest, removal of
sequestra, in case they are in the alveolar part of bone. The
wound is closed preferably primarily, with a drain.
Prognosis : If proper aggressive and comprehensive
therapy is instituted on time, then, the recovery of acute
and chronic OML is always good. But, in cases of chronic
refractory or diffuse sclerosing OML, associated with
regional or systemic disease, such as microvascular or
immunosuppressive disorders, the treatment may be worse
than the disease itself.
In these cases, attempt should be done to provide long – term
conservative therapy than major surgical debridement. Long
term use of salicylates, nonsteroidals or steroids with
laboratory monitoring is advised in some of these cases.
The treatment regimen will have to be modified depending
on the status of general health of the patient.
Infantile OML( OML Maxillaries Neonatorum,
Maxillitis of infancy) :It is a rare type of OML seen in
infants involving maxilla. Wilensky (1932) described
OML in infants in a comprehensive manner.
ETIOLOGY: (1)Trauma: The access may be through a
break in the mucosa. Perinatal trauma caused to oral
mucosa during delivery. (2) Infection of maxillary sinus
(3) Paunz (1926) and Ramon et al. (1977) believe that
the disease is caused by infections from the nose. (4)
Hematogenous invasion by streptococci and
pneumococci
Clinical features-
Almost seen a few weeks after birth. There is sudden
onset and acute course. The disease may also have slow
onset and a chronic course. In acute stage , severe pain
and high fever ; and with chronic course there is moderate
pain and slight fever.
General constitutinal manifestations : Pyrexia, anorexia,
dehydration, convulsions, or vomitting may occur.
Treatment-
The treatment should be prompt and aggressive.
Antibiotics preferably be given by IV route. Penicillins or
penicillinase – resistant penicillins like flucloxacillin, or
broad – spectrum antibiotics may be given for 2-4 weeks.
 Incision and drainage of fluctuant areas : It is indicated
in the presence of of periosteal or palatal abscesses.
Irrigations: In case of sinus tracts, irrigations are done
frequently.
Supportive therapy: (i) Analgesics and antipyretics, (ii)
fluids (iii) Proper diet.
Sequestrectomy or removal of necrotic tooth germs:
Removal of sequestra is undertaken when they are
completely separated, and on the basis of clinical and
radiological findings. Surgical interference should be
conservative; as loss of bone and teeth leads to severe
deformities later in life.
Children who have undergone sequestrectomies, should be
followed up by an orthodontist to aid in the development of
the arch and maintenance of occlusion.
Garre’s Sclerosing Osteomyelitis: Also known as chronic
nonsuppurative sclerosing OML, chronic OML with
proliferative periostitis, and periostitis ossificans . It was
first described Carl Garre (1893) , as irritation induced focal
thickening of periosteum and cortical bone of tibia. It is a
nonsuppurative inflammatory process; where there is
peripheral subperiosteal bone deposition caused by mild
irritation and infection.
Pathogenesis : The etiological agents can be a carious tooth,
or the overlying soft tissue infection. The infectious process
localizes in periosteum or beneath the periosteal covering of
cortex and spreads slightly into the inferior of bone .
 Clinical features: It is characterized by: (i) localized hard,
nontender bony swelling of lateral and inferior aspects of
mandible, (ii) lymphadenopathy, hyperpyrexia and
leukocytosis usually not found
Treatment: It is directed towards removing sources of
inflammation : (a) Removal of infected tooth and curettage
of socket, (b) Surgical recontouring : This is done to
recontour the cortical expansion of the jaw. This is
attempted only if there is obvious expansion, (c)
Endodontic therapy , (d) Antibiotics : If signs of infection
are present and (e) follow – up.
Chronic Sclerosing OML (focal and diffuse) :
The various other names are sclerosing osteitis, ossifying
OML, sclerosing cementoma, gigantiform cementoma,
and sclerotic cemental masses.
Focal form: (I) Below the age of twenty, (II) More common
in mandible, (III) Associated with infected pulp of lower
molars /premolars, (iv) Appears as circumscribed
radiopaque mass of sclerotic bone associated with tooth
roots, (v) Margins may be distinct or may blend into
surrounding bone.
Treatment: Endodontic therapy or Extraction.
Multiple form: These occur in both maxilla and mandible
(resembles chronic suppurative OML). Pain is a prominent
feature. Suppuration is usually absent.
Treatment: Debridement, antibiotic therapy, alveolectomy,
and HBO2, etc.
Actinomycotic OML of jaws : It is a chronic infection
manifesting both granulomatous and suppurative features ;
and usually involved soft tissues and occasionally bone.
Pathogenesis: Organisms gain entry into soft tissues directly
or by extension from bone through (i) Periapical, or (ii)
Periodontal lesions and (iii) Fractures, or (iv) Extraction
sites.
Clinical features:
Soft or firm tissue masses on the skin ; which have
purplish, dark red, oily areas with occasional small zones
of fluctuation.
Spontaneous drainage of serous fluid containing granular
material. These granules are yellowish substances called
sulfur granules , and represent colonies of bacteria.
Regional lymph nodes are occasionally enlarged.
Trismus: Not common ; unless secondary infection
Pyrexia
Management: In the past, many therapeutic agents and
techniques were used including: (a) Iodides (b)
Radiation (c) Incision and drainage (d) Excision of soft
tissues and bone. Currently, iodides and radiotherapy
are considered to be ineffective.
Mucormycosis is a rare opportunistic fungal infection with
high morbidity and mortality
3rd most common Angio- invasive fungal infection (after
candidiasis and aspergillosis)
 Majority of the patient has underlying risk factor
Immuno-compromised patient
Mucormycosis is caused by the fungal organisms of the
family of Mucorale (Mucor, Rhizopus and Absida).
Represents 8.3%-13% of all fungal infections
In developed countries, the disease remain uncommon is
mostly seen in patients with diabetes mellitus and
hematological malignancies undergoing chemotherapy.
In developing countries, especially in India,
mucormycosis cases although sporadic, occur mainly in
patients with uncontrolled diabetes or trauma.
Inoculation occurs when spores reach the nasal cavity
during inhalation.
Tiny spores then become airborne and land on the oral and
nasal mucosa of humans.
Angio-invasion
 Vessel thrombosis
Tissue necrosis
Hematogenous spread to other organs can occur.
Rhino-orbitocerebral
Cutaneous /subcutaneous
Gastrointestinal
Pulmonary
Dissiminated
Uncommon Presentation
Stage 1: Sino-nasal disease
Stage 2: Rhino-orbital disease
Stage 3: Rhino-orbital- cerebral disease
Sinusitis
Unilateral facial swelling
Periorbital cellulitis
Eye Or facial pain and facial numbness
Conjuctival suffusion
Blurred vision
Low-grade fever
Increased white blood cell counts
Opthalmoplegia
Chemosis
The nasal turbinates on the affected side may be dusky red
or necrotic black.
Palatal involvement is usually the result of direct
extension of disease from the maxillary sinus and in the
distribution of the nasopalatine and greater palatine
arteries.
Oral and skin ulcerations are present with pain and
swelling
Plain orbit or sinus radiography
CT
MRI
Early diagnosis: small, focal lesions can often be surgically
excised before they progress to involve critical structures.
Antifungal therapy:
Amphotericin B : Initially a test dose- 1mg in 20 ml of
5%dextrose in water is infused intravenously over 20-30
minutes
With careful monitoring for side effects (i.e, chills, fever, and
anaphylaxis) every 30 minutes for 2to4 hours.
 If this dose is well tolerated – An initial dose of 0.1 to 0.3
mg/kg/day is then prepared as a 0.1mg /ml infusion and
delivered slowly over 6-24 hours .
Gradually increased by 5 to 10 mg per day, upto a total
dose of 0.7to1 mg /kg/day.
But a single dose should exceed 1.5 mg/kg /day ; as
overdoses can result in cardiorespiratory arrest.
 Liposomal Amphotericin B:
 First line recommended agent
 Can be given as 5mg/kg/day to 10 mg/kg/day
 Surgery + Liposomal Amphotericin B increases survival
rates and cure rates.
Posaconazole :
Dose : 800 mg/day divided in 4
 Isavuconazole:
Available in oral and intravenous formulations.
Administered with a loading dose of 200 mg 3 times a
day for 2 days and 200 mg daily thereafter.
Fluconazole , voriconazole, and itraconazole do not have
reliable activity against mucormycosis.
Surgical debridement:Extensive and early surgical
debridement is necessary.
Therefore, debridement of necrotic tissues may be
important for complete eradication of mucormycosis.
Surgical management include:
Debridement of the necrotic part
Drainage of the sinuses
Total and subtotal maxillectomy
Palatectomy
Sphenoid and ethmoid sinusectomy
Exerts a fungistatic effect
Aids in neovascularization
Dose: exposure to 100% oxygen for 1 and ½ hours
at pressures from 2-2.5 atm with 1or 2 exposures
daily for a total of 40 treatments.
Mucormycosis is a fatal infection.
Early recognition will prevent further dissemination of
disease.
Medical as well as surgical management plays equal role
in its treatment.
Osteomyelitis, although uncommon, continues to be seen
and treated by dentists and oral and maxillofacial
surgeons.
Complete therapy involves both medical and surgical
approaches in an effort to achieve total care.
Osteomyelities.pptx

More Related Content

Similar to Osteomyelities.pptx

Osteomielitis
OsteomielitisOsteomielitis
Osteomielitis
Sajjad AL-Yossify
 
osteomyelitis of jaw bones / dental implant courses by Indian dental academy 
osteomyelitis of jaw bones / dental implant courses by Indian dental academy osteomyelitis of jaw bones / dental implant courses by Indian dental academy 
osteomyelitis of jaw bones / dental implant courses by Indian dental academy 
Indian dental academy
 
Osteomyelitis.pptx
Osteomyelitis.pptxOsteomyelitis.pptx
Osteomyelitis.pptx
DrPrashantMJadav
 
osteomyelitis.ppt
osteomyelitis.pptosteomyelitis.ppt
osteomyelitis.ppt
aatirjavaid1
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
King Jayesh
 
Inflammatory disease of bones
Inflammatory disease of bonesInflammatory disease of bones
Inflammatory disease of bones
Eneutron
 
Chronic infections of jaws
Chronic infections of jaws  Chronic infections of jaws
Chronic infections of jaws
Mohammed Haneef Farooq
 
bone diseases.pptx
bone diseases.pptxbone diseases.pptx
bone diseases.pptx
MohammedAbdela7
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
somebodyma
 
Chronic pyogenic osteomyelitis
Chronic pyogenic osteomyelitis Chronic pyogenic osteomyelitis
Chronic pyogenic osteomyelitis
Dr. Punit Gaurav
 
Osteomylitis.pdf
Osteomylitis.pdfOsteomylitis.pdf
Osteomylitis.pdf
ANDREWODHIAMBO12
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
Sagar Tomar
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
Mohanad Mohanad
 
osteomyelitis.pptx
osteomyelitis.pptxosteomyelitis.pptx
osteomyelitis.pptx
ArchiniKrishnamurtty1
 
Acute osteomyelitis
Acute osteomyelitisAcute osteomyelitis
Acute osteomyelitis
DrArhabALSHABI
 
Inflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptx
Inflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptxInflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptx
Inflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptx
Manal445405
 
Infection of bone
Infection of boneInfection of bone
Infection of bone
OM VERMA
 
Pulp and periapical disease
Pulp and periapical diseasePulp and periapical disease
Pulp and periapical disease
Malabar Dental College
 
Osteomyelitis, acute, chronic,multifocal. classification, treatment
Osteomyelitis, acute, chronic,multifocal. classification, treatment Osteomyelitis, acute, chronic,multifocal. classification, treatment
Osteomyelitis, acute, chronic,multifocal. classification, treatment
Dr.Nikhil. S.U
 
Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf
Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdfOsteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf
Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf
RebiraWorkineh
 

Similar to Osteomyelities.pptx (20)

Osteomielitis
OsteomielitisOsteomielitis
Osteomielitis
 
osteomyelitis of jaw bones / dental implant courses by Indian dental academy 
osteomyelitis of jaw bones / dental implant courses by Indian dental academy osteomyelitis of jaw bones / dental implant courses by Indian dental academy 
osteomyelitis of jaw bones / dental implant courses by Indian dental academy 
 
Osteomyelitis.pptx
Osteomyelitis.pptxOsteomyelitis.pptx
Osteomyelitis.pptx
 
osteomyelitis.ppt
osteomyelitis.pptosteomyelitis.ppt
osteomyelitis.ppt
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Inflammatory disease of bones
Inflammatory disease of bonesInflammatory disease of bones
Inflammatory disease of bones
 
Chronic infections of jaws
Chronic infections of jaws  Chronic infections of jaws
Chronic infections of jaws
 
bone diseases.pptx
bone diseases.pptxbone diseases.pptx
bone diseases.pptx
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Chronic pyogenic osteomyelitis
Chronic pyogenic osteomyelitis Chronic pyogenic osteomyelitis
Chronic pyogenic osteomyelitis
 
Osteomylitis.pdf
Osteomylitis.pdfOsteomylitis.pdf
Osteomylitis.pdf
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
osteomyelitis.pptx
osteomyelitis.pptxosteomyelitis.pptx
osteomyelitis.pptx
 
Acute osteomyelitis
Acute osteomyelitisAcute osteomyelitis
Acute osteomyelitis
 
Inflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptx
Inflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptxInflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptx
Inflammatory bone diseases & bone fracture_Dr.Manal Ismail Abd-Elghany_2022.pptx
 
Infection of bone
Infection of boneInfection of bone
Infection of bone
 
Pulp and periapical disease
Pulp and periapical diseasePulp and periapical disease
Pulp and periapical disease
 
Osteomyelitis, acute, chronic,multifocal. classification, treatment
Osteomyelitis, acute, chronic,multifocal. classification, treatment Osteomyelitis, acute, chronic,multifocal. classification, treatment
Osteomyelitis, acute, chronic,multifocal. classification, treatment
 
Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf
Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdfOsteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf
Osteomyelitis, osteoarthritis, Rheumatoid arthritis.pdf
 

Recently uploaded

REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 

Recently uploaded (20)

REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 

Osteomyelities.pptx

  • 2. The words, “osseous” in latin means bony, and “osteon” in Greek means “bone”, and ‘‘myleos’’ means marrow; and “itis” in Greek means inflammation. In 1834, Nelaton first coined the word “Osteomyelitis”. By definition osteomyelitis (OML) is an inflammation of medullary portion of bone or bone marrow or cancellous bone.
  • 3.  Osteomyelitis is an extensive inflammation of a bone. It involves the cancellous portion, bone marrow ,cortex and periosteum. ( Laskin1989)
  • 4. The inflammation may be acute, subacute or chronic. It may be localized ; or may involve a larger portion of bone. It may be suppurative or nonsuppurative.
  • 5. The factors that predispose to osteomyelitis are: 1. Conditions affecting host resistance or defenses 2. Compromised vascular integrity and perfusion in the host bone, at the local, regional or systemic level 3. Virulence of microorganisms
  • 6. 1. Conditions that alter host defenses would include chronic debilitating diseases, such as diabetes mellitus, agranulocytosis, leukemia , severe anemia, malnutrition, drug abuse, chronic alcoholism, sickle cell disease, and febrile illnesses such as typhoid, tuberculosis. 2. Conditions that alter vascularity of bone include therapeutic irradiation, osteoporosis, Paget’s disease, fibrous dysplasia, peripheral vascular disease, bone malignancy, metallic bone necrosis (caused by mercury, bismuth, and arsenic).
  • 7. 3. Virulence of organisms: Certain organisms precipitate thrombi formation by virtue of their destructive lysosomal enzymes (Hudson 1993). Lysosomal and enzymatic degradation of host tissue, along with microvascular thrombosis brought about by pathogen borne bioactive peptides and chemoattracted leukocytic purulence, forms a protective barrier for the infectious foci, allowing organisms to proliferate in an enriched host medium, while protected from the host immunity.
  • 8. Osteomyelitis of the jaws is caused by: Odontogenic infections: Primarily odontogenic infections originating from pulpal or periodontal tissues, pericoronitis, infected socket, infected cyst, tumor, etc. Trauma: Is the second leading cause : (a) Especially, compound fracture and (b) Surgery – iatrogenic cause. Infections of orofacial regions derived from : Periostitis following gingival ulceration, lymph nodes infected from furuncles, lacerations, peritonsillar abscess.
  • 9. Infections derived by hematogenous route: Furuncle on face, wound on the skin, upper respiratory tract infection, middle ear infection, mastoiditis, systemic tuberculosis. The medications linked to osteomyelitis are steroids, chemotherapeutic agents and bisphosphonates. Local conditions that adversely affect the blood supply can also predispose the host to a bony infection.
  • 10. Osteomyelitis is initiated from a contiguous focus of infection or by hematogenous spread Primary hematogenous osteomyelitis is rare in the maxillofacial region , generally occurring in the very young patients The adult process is initiated by an inoculation of bacteria into the jaw bones
  • 11. The initial causative insult results in a bacteria induced inflammation or cascade In normal healthy patient, this process will be self-limiting Osteomyelitis is an infectious process of the medullary myeloid cavity of bone In the craniofacial skeleton , only the mandible and the calvarium have myeloid compartments
  • 12. The important factor in the establishment of osteomyelitis is the compromise in the blood supply .
  • 13.
  • 14.
  • 15. Primary supply: The mandible is supplied by inferior alveolar artery, except coronoid process, which is supplied by temporalis muscle vessels. Secondary supply: It is periosteal supply, which generally runs parallel to cortical surface of bone, giving off nutrient vessels, those penetrate cortical bone and anastomose with the branches of inferior alveolar artery. Venous drainage of mandible: There are two routes: (1) Via inferior alveolar vein ; it runs upwards, and joins pharyngeal plexus, and (2) It runs downwards, and joins external jugular veins. Waldron(1943) , gave an exhaustive morphologic description of vascular morphology of mandible and associated structures
  • 16. to account for spread of OML. He described mandibular vascular support as being provided through multiple arterial loops from a single major vessel, which renders large portion of bone susceptible to necrosis with the occurence of major vessel infectious thrombosis.  Waldervogel (1970): described its relationship to vascular support of long bones of developing and adult human skeleton . He made several conclusions : There tends to be segregation of vascular channels, which act like “end organs”, due to lack of terminal collateral anastomosis, ultimately, leading to vascular plugging by bacteria, microthrombi or both. When afferent vessels anastomose with medullary channels
  • 17. , there is a possibility of a decrease in venous flow with associated areas of greater turbulence.  There may be a reduction in host immune defense mechanism associated with these vascular channels in calcified tissue.
  • 18. A true osteomyelitis infectious process does not occur in the maxilla despite the presence of tooth follicle or anatomic respiratory sinus cavities, including the nose. It is rare , due to: (1) Extensive blood supply and significant collateral blood flow in midface, (2) Porous nature of membranous bone, (3) Thin cortical plates, and (4) Abundant medullary spaces. These preclude confinement of infections within bone ; and permit dissipation of edema and pus into soft tissues and paranasal air sinuses.
  • 19.
  • 20. The process of leading to OML is initiated by acute inflammation, hyperemia, increased capillary permeability and infiltration of granulocytes. Tissue necrosis occurs, as proteolytic enzymes are liberated and as destruction of bacteria and vascular thrombosis continues, there is a pus formation. The pus is a combination of necrotic tissue and dead bacteria and white blood cells accumulate. When pus accumulates, the intermedullary pressure increases resulting in vascular collapse, venous stasis, and ischemia.
  • 21. Subsequently, pus travels through Haversian and nutrient canals and accumulates beneath the periosteum, elevating it from the cortex ; and thereby further reducing vascular supply. Compression of neurovascular bundle accelerates thrombosis, ischemia, and infarction, later resulting in paresthesia and sequestrum formation. A sequestrum is defined as a portion of bone that becomes separated from sound bone during the process of necrosis. Radiographically, the bone surrounding sequestrum appears less densely mineralized than sequestrum itself, since vascularity of vital bone creates relative demineralization.
  • 22. In the past, etiology of OML was associated with skin surface bacteria, Staphylococcus aureus, and to a lesser extent Staphylococcus epidermidis, or hemolytic streptococci. However, the picture of S.aureus as primary offending pathogen does not hold true with regard to OML of tooth bearing bone. Most of the cases are caused by aerobic Streptococci (alpha hemolytic streptococci, Streptococcus viridans), anaerobic streptococci; and other anaerobes, such as Peptostreptococci, fusobacteria, and Bacteroides.
  • 23. Other organisms, such as M. tuberculosis , T. Pallidum, and Actinomyces species produce their respective specific forms of OML. Hence, established acute OML is usually a polymicrobial disease and includes : Streptococci, Bacteroides, Peptostreptococci and Fusobacteria.
  • 24. A variety of classifications of various forms of the disease are:  Historically accepted classification : It is based on clinical course. (A) Acute, (B) Chronic. The arbitrary time limit, to identify acute from chronic form is of 1 month (Koorbusch et al. 1992, Marx; 1992, and Mercuri ; 1992) .
  • 25.
  • 26. Classification based on presence or absence of suppuration:
  • 27. Cierny et al. (1985) and Vibhagool (1993) developed a classification and staging system; based on: 1. Anatomic location of infectious process, 2. Physiological status of the host, 3. Systemic or local factors affecting immune system, metabolism, and local vascularity.
  • 28.
  • 29. It may have the appearance of a typical odontogenic infection. It can be localized and widespread, with extensive sequestration and possible pathological fracture.
  • 30. It is caused by pyogenic organisms. OML in the tooth bearing area, is polymicrobial in nature. The most commonly found organisms in odontogenic OML is Staphylococcus aureus, and Streptococcus pyogenes.
  • 31. 1. Odontogenic infections 2. Local traumatic injuries 3. Peritonsillar abscess 4. Furunculosis 5. Hematogenous infections 6. Infected compounded odontoma 7. Compound fractures of jaws are complicated by OML.
  • 32. These are the common local cause of OML. These infections may result from: periapical disease secondary to pulp pathology, periodontal disease, pericoronitis of long duration, infected odontogenic cyst, and infection of an extraction wound or fracture site.
  • 33.
  • 34. Injuries of gingiva are usually insignificant; however may become serious in patients with low resistance (Ivy and Cook, 1942). Instruments used for extraction of teeth.
  • 35. PERITONSILLAR ABSCESS: It has been recorded as a cause of OML of ascending ramus. FURUNCULOSIS: Of skin is a rare cause of OML. HEMATOGENOUS INFECTION : It may cause multiple sites of OML. The organisms enter the bloodstream through a minor wound in the skin, or infection of upper respiratory tract, or infection of middle ear.
  • 36. 1. Undernourished children 2. Lowered general resistance of body 3. Generalized body diseases, such as : diabetes, leukemia and agranulocytosis 4. Acute illnesses such as influenza, measles, scarlet fever, pertussis and pneumonia, etc.
  • 37. OCCURENCE: In adults, it is more common in mandible and involves alveolar process, angle of mandible, posterior part of ramus and coronoid process. OML of condyle is reportedly rare (Linsey, 1953).  Early cases are characterized by : Generalized constitutional symptoms: high intermittent fever, malaise, nausea, vomiting, anorexia. Continuous intense pain in the affected area.
  • 38. Intermittent paresthesia or anesthesia of the lower lip, which helps the clinician to differentiate this condition from alveolar abscess. Facial cellulitis, or indurated swelling of moderate size, which is more confined to the periosteal envelope and its contents (I) Thrombosis of inferior alveolar vasa nervorum, (II) Rise in pressure from edema in inferior alveolar canal (III) Teeth are tender to percussion and loose, and presence of trismus. In children : fluminating, severe and serious, involvement of maxilla or mandible, complicated by the presence of unerupted developing teeth buds, which become necrotic
  • 39. and act as foreign bodies and prolong the disease process. Long- term involvement of temporomandibular joint (TMJ) can cause ankylosis of TMJ and subsequently affect the growth and development of facial structures. Laboratory studies : Show mild leukocytosis [poly- morphonuclear leukocytes (PMNL)] and albuminuria.
  • 40. Established cases are characterized by : Deep pain, malaise, fever, dehydration, anorexia Teeth in involved area begin to loosen and become sensitive to percussion. Purulent discharge through sinuses : (a) Intraorally, around gingival sulcus or through buccal vestibule, and (b) Extraorally on the face, through cutaneous fistulae Fetid odor is often present . Dehydration, acidosis and toxemia. Regional lymphadenopathy is usually present.
  • 41. Laboratory studies show: moderate leukocytosis, slightly elevated erythrocyte sedimentation rate (ESR) and C reactive protien, anemia and albuminuria. MANAGEMENT – Removal of the cause and debridement with antibiotic cover.
  • 42. It can be primary: resulting from organisms which are less virulent, and secondary occuring after acute OML, when the treatment did not succeed in eliminating the infection
  • 43. The clinical features are usually limited to : Pain and tenderness : the pain is minimal Nonhealing bony and overlying soft tissue wounds with induration of soft tissues, Intraoral or extraoral draining fistulae. Thickened or “wooden” character of bone. Enlargement of mandible because of deposition of subperiosteal new bone . Sterile abscess (Brodie’s abscess) , common to long bones is rare in jaws. Teeth in the area tend to become loose and sensitive to palpation and percussion.
  • 44. It is made on basis of : history, clinical examination and radiological findings — 1) Presence of sequestra, (2) Areas of suppuration involving the tooth –bearing area of jaw bone, not responding to debridement and conservative therapy, (3) Regional or systemic compromise of immune response, microvascular decompensation or both.
  • 45. Several sequalae/complications can occur as a result of OML of jaws. Neoplastic transformation: With chronic OML, neoplastic conversion of inflammatory metaplasia to squamous cell carcinoma is noted. The incidence reported is 0.2-1.5%. Discontinuity defects: The defects can be (a) spontaneous (b) surgically induced, necessitating jaw reconstruction ; once infection is resolved.
  • 46.
  • 47. Progressive diffuse sclerosis : It involves the medullary and cortical portions of maxillofacial skeleton, especially mandible, over a period of time.
  • 48. The overall treatment modalities include: 1. Conservative treatment 2. Surgical treatment  The goal of the treatment is to: 1. Attentuate and eradicate proliferating pathological organisms 2. Promote healing 3. Re-establish vascular permeability.
  • 49. Successful treatment is based on the following fundamental principles : 1. Early diagnosis with radiographic evaluation and tissue histopathology diagnosis 2. Bacterial culture and sensitivity testing 3. Adequate, appropriate and prompt antibiotic therapy 4. Adequate pain control 5. Proper surgical intervention 6. Reconstruction, where indicated.
  • 50. Complete bed rest Supportive therapy: It includes – nutritional support, in the form of high protein and high caloric diet, and adequate multivitamins Dehydration: Hydration orally or through administration of IV fluids Blood transfusion : In case, RBCs and hemoglobin is low Control of pain: It is controlled with analgesics. Sedation may be employed for keeping patient comfortable and allow to sleep.
  • 51. Antimicrobial agents : Begin with empiric dual drug therapy— Penicillin and metronidazole or single drug Clindamycin. Definitive antimicrobial therapy can be started after final culture and sensitivity test results are obtained. Antibiotics of value in treatment of OML include: penicillins, penicillinase-resistant penicillins, clindamycin, cephalosporins and erythromycins. Some of the newer antibiotics which provide effective coverage include: metronidazole, clindamycin, ticarcillin, clavulanic acid, cephalosporins, vancomycin in combination with other antibiotics, and fluoroquinolones.
  • 52. Recommended antibiotic regimens for OML of jaws are as follows: Regimen I (1st choice) : As empirical therapy, penicillin (penicillin V) is given. Aqueous penicillin: 2 million units IV every 4 hourly. Oxacillin: 1g IV every 4 hourly. When the patient has been asymptomatic for 48-72 hours, then switch to—penicillin V orally 500mg every 4 hourly, with dicloxacillin 250 mg orally every 4 hourly for 2-4 weeks.  Regimen II: It is based on culture and sensitivity results. Penicillinase penicillinase-resistant penicillins, such as oxacillin, cloxacillin, dicloxacillin, or flucloxacillin may be given.
  • 53. In case of allergy to penicillin, the following antibiotics are prescribed, in order of preference: (i) Clindamycin 300-600 mg orally 6 hourly, (ii) Cephalosporin 250-500mg orally every 6 hourly: (a) Cefazolin 500 mg 8 hourly, or (b) Cephalexin 500 mg 6 hourly, (iii) Erythromycin 2g every 6 hourly IV, then 500 mg every 6 hourly orally. Second choice: Clindamycin: It is effective against penicillinase producing staphylococci, streptococci and anaerobic bacteria including Bacteroides. It is used because of its ability to diffuse widely in bone. It is nkt recommended as first choice; as it is bacteriostatic, and causes diarrhea due to pseudomembranous colitis.
  • 54. Third choice : Cefazolin or Cephalexin : It is effective against most cocci including penicillinase –producing staphylococci, Gram-negative aerobic bacilli viz. E. coli , Klebsiella, and Proteus. Cephalosporins are not recommended as first choice because these are moderately effective against anaerobes and because of broad spectrum coverage, which increases antibiotic complications. Fourth choice: Erythromycin : These drugs cannot be used as first choice, as these are : (i) Bacteriostatic, and (ii) rapidly develop resistant strains.
  • 55. Over the last several decades, HBO therapy has emerged as : (i) a potent alternative to surgical reperfusion, and (ii) as an adjunctive enhancement to host –immune response. Its use has increased in the treatment of refractory OML and osteoradionecrosis (ORN) . The hyperbaric oxygen therapy is indicated in cases of osteomyelitis , which do not respond to routine treatment due to presence of certain associated conditions like irradiated jaw , osteosclerosis , osteoporosis , and geriatric patients.
  • 56. It facilitates the healing of the bone and also helps in combating the infection . The HBO therapy involves the intermittent ,twice daily, inhalation of 100% humidified oxygen under 2 atmospheric pressure for 90 minutes . HBO reduces the hypoxia within the affected tissues and stimulates angiogenesis in the hypovascular tissues. It enhances phagocytic activity of leukocytes to stimulate fibroblast growth , increase in collagen formation and promote growth of new capillaries.
  • 57. Hyperbaric oxygen chamber : The patient is placed in a chamber. Oxygen is given by mask or by hood .It is given for 5 days per week for 30, 60, or more dives at 2.4 ATA for 90 minutes , while breathing 100% oxygen twice daily.  Marx protocol (1983 ): • 30 initial dives, if improved then 60 dives completed • Otherwise , sequestrectomy +30 dives • If wound dehiscence , resection + 60 dives and 20 dives after 10 weeks • Patient with pathological fracture , orocutaneous fistula are given 30 dives more prior going to resection.
  • 58.
  • 59. The surgical treatment modalities include: 1. Incision and drainage 2. Extraction of loose or offending teeth 3. Debridement 4. Decortication 5. Continuous or intermittent indwelling close catheter irrigation
  • 60. 6. Sequestrectomy 7. Saucerization 8. Resection of jaw 9. Trephination 10. Immediate or delayed reconstruction with bone graft. Surgical intervention is done under antibiotic cover, started atleast, 1-2 days prior to the procedure.
  • 61. It should be done as soon as possible. It relieves the pressure and pain caused by the accumulation of pus. Incision of abscesses should be carried out intraorally or extraorally depending upon the location. Evacuation of pus by drainage, lessens absorption of toxic products and prevents further spread of infection in the bone, thus, helping in its localization. The consistency, color and odor of the pus may provide important clues to the diagnosis and initial treatment. Patients with compromised systemic conditions or toxemia, surgical interference may be postponed for 2-3 days.
  • 62. The various methods employed for causing drainage from the bone include: (i) Opening up the pulp chamber, (ii) By making fenestration through cortical plate over the apical area with a drill, (iii) In an edentulous area, especially, posterior maxilla or maxillary tuberosity region, by making an incision over the alveolar crest, and by making a window, pus is evacuated and (iv) OML at the angle of mandible or ascending ramus, drainage can be achieved by a small incision made over the point of the greatest tenderness, or just below the mandible.  Extraction of loose or offending teeth: Sometimes, drainage is achieved by extraction of offending teeth.
  • 63. Debridement : followed by incision and drainage, thorough debridement of affected area should be carried out. The area may be irrigated with hydrogen peroxide and saline. Any foreign body, necrotic tissue or small sequestrum should be removed. Decortication: Removal of dense chronically infected and poorly vascularized, lateral and inferior cortical plates of bone 1-2 cm beyond the area of involvement. Thus, an access is provided to medullary cavity. Obwegeser (1960) advocated this procedure, as it shortens healing time. Decortication and mobilization of muscle flaps to achieve or improve regional and systemic vascular supply to the involved area have been used to bring the overlying vascular soft tissue envelope to a closer proximity to infected spongiosa.
  • 64. This will increase the blood supply and healing of the affected area. The steps in decortication are: Creation of buccal flap by crestal incision extending along the necks of the teeth. Reflection of mucoperiosteal flap to the inferior border. Removal of teeth in the involved area. Removal of cortical plates —lateral and inferior border, with chisel in one piece. Bone must be cut back to uninvolved areas. Bony bed should be thoroughly debrided and flaps should be closed primarily and dead space is eliminated by applying pressure bandage placed to keep vascularized soft tissue in contact with bony bed.
  • 65. Irrigation tubes should be placed through separate stab incision and closed suction should be employed.
  • 66. Continuous or intermittent indwelling closed catheter irrigation : After intraoral sequestrectomy and saucerization or decortication, two small pediatric nasogastric feeding tubes, catheters or polyethylene drain tubes, 3-4 mm in diameter and 6-10 inches long in length, are placed against the bony bed through separate skin incisions at some distance and secured with sutures. One tube is connected to the low – pressure suction to allow drainage of pus and serum and another is kept patent to provide a route through which locally antibiotics may be instilled in very high concentrations. Daily, first saline irrigation followed by antibiotic instillation should be repeated, until negative cultures are obtained. Systemic antibiotics are also continued for atleast 2-3 months following cessation of clinical evidence of disease.
  • 67. Sequestrectomy: An integral part of definitive therapy. It helps in establishment of local microvascular proliferation. It should be undertaken through an intraoral incision; or extraoral ( submandibular) approach, depending upon the site of sequestrum. Saucerization: Excision of margins of necrotic bone overlying a focus of OML. It is useful in chronic form, since it permits removal of formed and forming sequestra with better visualization. It is performed when removal of sequestrum leaves a large cavity, and to eliminate the dead space to avoid reinfection of extensive clot. It is performed with a large round bur, so that when wound is closed, the soft tissues eliminate a dead space. The buccal cortex is reduced to the level of unattached mucosa, producing a saucer like defect.
  • 68.
  • 69.
  • 70. Sequestrectomy and saucerization are to be carried out after the acute phase has subsided; and the defense mechanism of host and antimicrobial therapy have overcome the virulence of organisms. In certain circumstances, after performing the necessary surgical procedures, where the soft tissues cannot be closed without leaving dead space, or because of rigid fibrosis ; the wound may be packed with 2” ribbon gauze soaked with Whitehead varnish. Trephination Or fenestration is the creation of bony holes or windows in the overlying cortical bone adjacent to the infectious process for tissue ammoniation and decompression of the medullary compartment. Drilling of holes into the cortex and reaching medulla provides multiple
  • 71.
  • 72. surgical transcortical ports, that allow vascular communication between the periosteum and the medullary cavity.  Resection : It is rarely required. When full thickness of segment of jaw is involved and a conservative approach has failed to cure, resection of the part should be considered. However, while exposing the affected area, the only soft tissue related to the necrotic bone should be elevated, to avoid devitalization of the adjoining cortex.
  • 73.
  • 74. Immediate and/or delayed reconstruction : It has been used successfully in cases of: (i) pathological fracture, (ii) persistence of infection after decortication, and (iii) when both cortical plates are markedly diseased . Iliac crest is a desirable graft. A block of corticocancellous iliac crest can be used or cancellous marrow is used. Stabilization may be achieved with vitallium or titanium mesh that also serves as a tray to contain the graft. Immediate reconstruction offers the obvious advantage of shortening the period of illness and speeding recovery and rehabilitation. In cases, where immediate bone grafting is contraindicated, a reconstruction plate is fixed as a spacer.
  • 75. Secondary bone grafting: This should be considered when the wound has healed completely and is free of infection. Postoperative care: It includes the following :(i) Continued use of antibiotics, analgesics, and hot saline mouth rinses, (ii) Adequate hydration, complete rest, removal of sequestra, in case they are in the alveolar part of bone. The wound is closed preferably primarily, with a drain. Prognosis : If proper aggressive and comprehensive therapy is instituted on time, then, the recovery of acute and chronic OML is always good. But, in cases of chronic refractory or diffuse sclerosing OML, associated with regional or systemic disease, such as microvascular or immunosuppressive disorders, the treatment may be worse than the disease itself.
  • 76. In these cases, attempt should be done to provide long – term conservative therapy than major surgical debridement. Long term use of salicylates, nonsteroidals or steroids with laboratory monitoring is advised in some of these cases. The treatment regimen will have to be modified depending on the status of general health of the patient.
  • 77.
  • 78. Infantile OML( OML Maxillaries Neonatorum, Maxillitis of infancy) :It is a rare type of OML seen in infants involving maxilla. Wilensky (1932) described OML in infants in a comprehensive manner. ETIOLOGY: (1)Trauma: The access may be through a break in the mucosa. Perinatal trauma caused to oral mucosa during delivery. (2) Infection of maxillary sinus (3) Paunz (1926) and Ramon et al. (1977) believe that the disease is caused by infections from the nose. (4) Hematogenous invasion by streptococci and pneumococci
  • 79. Clinical features- Almost seen a few weeks after birth. There is sudden onset and acute course. The disease may also have slow onset and a chronic course. In acute stage , severe pain and high fever ; and with chronic course there is moderate pain and slight fever. General constitutinal manifestations : Pyrexia, anorexia, dehydration, convulsions, or vomitting may occur. Treatment- The treatment should be prompt and aggressive. Antibiotics preferably be given by IV route. Penicillins or
  • 80. penicillinase – resistant penicillins like flucloxacillin, or broad – spectrum antibiotics may be given for 2-4 weeks.  Incision and drainage of fluctuant areas : It is indicated in the presence of of periosteal or palatal abscesses. Irrigations: In case of sinus tracts, irrigations are done frequently. Supportive therapy: (i) Analgesics and antipyretics, (ii) fluids (iii) Proper diet. Sequestrectomy or removal of necrotic tooth germs: Removal of sequestra is undertaken when they are completely separated, and on the basis of clinical and radiological findings. Surgical interference should be conservative; as loss of bone and teeth leads to severe deformities later in life.
  • 81. Children who have undergone sequestrectomies, should be followed up by an orthodontist to aid in the development of the arch and maintenance of occlusion. Garre’s Sclerosing Osteomyelitis: Also known as chronic nonsuppurative sclerosing OML, chronic OML with proliferative periostitis, and periostitis ossificans . It was first described Carl Garre (1893) , as irritation induced focal thickening of periosteum and cortical bone of tibia. It is a nonsuppurative inflammatory process; where there is peripheral subperiosteal bone deposition caused by mild irritation and infection. Pathogenesis : The etiological agents can be a carious tooth, or the overlying soft tissue infection. The infectious process localizes in periosteum or beneath the periosteal covering of
  • 82. cortex and spreads slightly into the inferior of bone .  Clinical features: It is characterized by: (i) localized hard, nontender bony swelling of lateral and inferior aspects of mandible, (ii) lymphadenopathy, hyperpyrexia and leukocytosis usually not found Treatment: It is directed towards removing sources of inflammation : (a) Removal of infected tooth and curettage of socket, (b) Surgical recontouring : This is done to recontour the cortical expansion of the jaw. This is attempted only if there is obvious expansion, (c) Endodontic therapy , (d) Antibiotics : If signs of infection are present and (e) follow – up.
  • 83. Chronic Sclerosing OML (focal and diffuse) : The various other names are sclerosing osteitis, ossifying OML, sclerosing cementoma, gigantiform cementoma, and sclerotic cemental masses. Focal form: (I) Below the age of twenty, (II) More common in mandible, (III) Associated with infected pulp of lower molars /premolars, (iv) Appears as circumscribed radiopaque mass of sclerotic bone associated with tooth roots, (v) Margins may be distinct or may blend into surrounding bone. Treatment: Endodontic therapy or Extraction.
  • 84. Multiple form: These occur in both maxilla and mandible (resembles chronic suppurative OML). Pain is a prominent feature. Suppuration is usually absent. Treatment: Debridement, antibiotic therapy, alveolectomy, and HBO2, etc. Actinomycotic OML of jaws : It is a chronic infection manifesting both granulomatous and suppurative features ; and usually involved soft tissues and occasionally bone. Pathogenesis: Organisms gain entry into soft tissues directly or by extension from bone through (i) Periapical, or (ii) Periodontal lesions and (iii) Fractures, or (iv) Extraction sites.
  • 85. Clinical features: Soft or firm tissue masses on the skin ; which have purplish, dark red, oily areas with occasional small zones of fluctuation. Spontaneous drainage of serous fluid containing granular material. These granules are yellowish substances called sulfur granules , and represent colonies of bacteria. Regional lymph nodes are occasionally enlarged. Trismus: Not common ; unless secondary infection Pyrexia
  • 86. Management: In the past, many therapeutic agents and techniques were used including: (a) Iodides (b) Radiation (c) Incision and drainage (d) Excision of soft tissues and bone. Currently, iodides and radiotherapy are considered to be ineffective.
  • 87.
  • 88. Mucormycosis is a rare opportunistic fungal infection with high morbidity and mortality 3rd most common Angio- invasive fungal infection (after candidiasis and aspergillosis)  Majority of the patient has underlying risk factor Immuno-compromised patient Mucormycosis is caused by the fungal organisms of the family of Mucorale (Mucor, Rhizopus and Absida).
  • 89. Represents 8.3%-13% of all fungal infections In developed countries, the disease remain uncommon is mostly seen in patients with diabetes mellitus and hematological malignancies undergoing chemotherapy. In developing countries, especially in India, mucormycosis cases although sporadic, occur mainly in patients with uncontrolled diabetes or trauma.
  • 90. Inoculation occurs when spores reach the nasal cavity during inhalation. Tiny spores then become airborne and land on the oral and nasal mucosa of humans. Angio-invasion  Vessel thrombosis Tissue necrosis Hematogenous spread to other organs can occur.
  • 91.
  • 93. Stage 1: Sino-nasal disease Stage 2: Rhino-orbital disease Stage 3: Rhino-orbital- cerebral disease
  • 94. Sinusitis Unilateral facial swelling Periorbital cellulitis Eye Or facial pain and facial numbness Conjuctival suffusion Blurred vision Low-grade fever Increased white blood cell counts
  • 96. The nasal turbinates on the affected side may be dusky red or necrotic black.
  • 97. Palatal involvement is usually the result of direct extension of disease from the maxillary sinus and in the distribution of the nasopalatine and greater palatine arteries.
  • 98. Oral and skin ulcerations are present with pain and swelling
  • 99. Plain orbit or sinus radiography CT MRI Early diagnosis: small, focal lesions can often be surgically excised before they progress to involve critical structures. Antifungal therapy: Amphotericin B : Initially a test dose- 1mg in 20 ml of 5%dextrose in water is infused intravenously over 20-30 minutes
  • 100. With careful monitoring for side effects (i.e, chills, fever, and anaphylaxis) every 30 minutes for 2to4 hours.  If this dose is well tolerated – An initial dose of 0.1 to 0.3 mg/kg/day is then prepared as a 0.1mg /ml infusion and delivered slowly over 6-24 hours . Gradually increased by 5 to 10 mg per day, upto a total dose of 0.7to1 mg /kg/day. But a single dose should exceed 1.5 mg/kg /day ; as overdoses can result in cardiorespiratory arrest.  Liposomal Amphotericin B:  First line recommended agent  Can be given as 5mg/kg/day to 10 mg/kg/day
  • 101.  Surgery + Liposomal Amphotericin B increases survival rates and cure rates. Posaconazole : Dose : 800 mg/day divided in 4  Isavuconazole: Available in oral and intravenous formulations. Administered with a loading dose of 200 mg 3 times a day for 2 days and 200 mg daily thereafter. Fluconazole , voriconazole, and itraconazole do not have reliable activity against mucormycosis.
  • 102. Surgical debridement:Extensive and early surgical debridement is necessary. Therefore, debridement of necrotic tissues may be important for complete eradication of mucormycosis. Surgical management include: Debridement of the necrotic part Drainage of the sinuses Total and subtotal maxillectomy Palatectomy Sphenoid and ethmoid sinusectomy
  • 103. Exerts a fungistatic effect Aids in neovascularization Dose: exposure to 100% oxygen for 1 and ½ hours at pressures from 2-2.5 atm with 1or 2 exposures daily for a total of 40 treatments.
  • 104. Mucormycosis is a fatal infection. Early recognition will prevent further dissemination of disease. Medical as well as surgical management plays equal role in its treatment. Osteomyelitis, although uncommon, continues to be seen and treated by dentists and oral and maxillofacial surgeons. Complete therapy involves both medical and surgical approaches in an effort to achieve total care.